LATS1 and chronic myelogenous leukemia, BCR-ABL1 positive: Due to the limited number of patient-derived CML cells, human erythroblastic CML K562 cells were used to study the biological effects of LATS1/2 on the survival and differentiation of human CML cells in vitro.